Polish 
English
| Approximate size of the job: | pages: 3 |
| Started: | 29 Jun 2008 @17:57 (GMT) |
| Job deadline: | 03 Jul 2008 @06:00 (GMT) |
| Quoting deadline: | 01 Jul 2008 @17:57 (GMT) ( expired ) |
| Started by: |
MONIKA LIPNIOWIECKA 609543906 00-732 warszawa |
| Job type: | Translation |
| Expertise (general): | Medical |
| Translation job description: | 3 STRONY Z BRITISH JOURNAL OF OPHTHALMOLOGY NA TEMAT LECZENIA WYSIęKOWEJ POSTACI STARCZEGO ZWYRODNIENIA PLAMKI (AMD). |
| Sample text: | The treatment of choroidal neovascularisation (CNV) in age related macular degeneration (AMD) has changed enormously during the last decade.1 While 10 years ago there was only argon laser coagulation, today we have several treatment options for classic, occult, and mixed subtypes available: classic CNV responds well to photodynamic therapy (PDT) with "off label" triamcinolone, while occult CNV can be treated by PDT, transpupillary thermotherapy (TTT), subretinal surgery, macular translocation, and antiangiostatic therapy. The choice often depends on a variety of personal and environmental circumstances. Firstly, increased age and reduced health status of the patient may exclude them from surgery. Secondly, while first eyes may benefit from subretinal surgery, second eyes may be eligible for macular translocation. Thirdly, the initial visual acuity (VA) and the type of lesion often limit the success in PDT and also the financial coverage by medical insurance. |
| Email to a friend |
| Report to moderator | |
job views: 254
| |